My MG Diagnosis Was a Shock, but I Learned to Trust the Journey

Soliris Is Safe and Effective in Real-world Use, Small US Study Shows

Soliris (eculizumab) safely and rapidly led to clinical benefits in people with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor antibody positive, according to data from a small real-world U.S. study. Moreover, most patients discontinued maintenance immunomodulatory treatment. The study, “Safety and outcomes of eculizumab for acetylcholine…

No Retreat: Learning to Manage My Medical Phobias

On March 4, 1933, U.S. President Franklin Delano Roosevelt told a fearful nation that “the only thing we have to fear is fear itself — nameless, unreasoning, unjustified terror which paralyzes needed efforts to convert retreat into advance.” Roosevelt’s words didn’t immediately end the financial chaos in the U.S. at…

MG Symptoms Weigh on Life Quality, Particularly for Women

People with myasthenia gravis, particularly women, have a high symptom burden that considerably affects their health-related quality of life, but the disease’s human cost is rarely given adequate study, a systematic literature review has found. Symptoms generally eased following treatment and disease remission. Still, there is…

After My MG Diagnosis, I Found Value in Togetherness

“I’d trade all of my tomorrows for one single yesterday.” The soulfulness of Janis Joplin’s voice and poignancy of Kris Kristofferson’s lyrics in “Me and Bobby McGee” have always resonated with me. The despair and longing are raw. Is there any return from that wasteland? Against my…

Agreement Reached to Market Efgartigimod in Israel, Europe

Medison Pharma has entered into a pact with the global immunology company Argenx to bring efgartigimod to market in Israel and across several European countries for treating adult patients with generalized myasthenia gravis (gMG). The agreement sets the stage for commercialization of efgartigimod in 14 countries: Hungary, Poland, Czech…